2025 |
SpringWorks Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
SpringWorks Therapeutics Inc
|
Independent Director |
625.2 K |
20.2 % |
2024 |
IGM Biosciences Inc
|
Independent Director |
291.8 K |
43.0 % |
2024 |
Erasca Inc
|
Independent Director |
138.4 K |
-16.2 % |
2023 |
SpringWorks Therapeutics Inc
|
Independent Director |
520.1 K |
-10.6 % |
2023 |
IGM Biosciences Inc
|
Independent Director |
204.1 K |
-49.9 % |
2023 |
Erasca Inc
|
Independent Director |
165.0 K |
-20.0 % |
2022 |
SpringWorks Therapeutics Inc
|
Independent Director |
582.1 K |
21.9 % |
2022 |
IGM Biosciences Inc
|
Independent Director |
407.4 K |
-10.9 % |
2022 |
Erasca Inc
|
Independent Director |
206.4 K |
-70.6 % |
2021 |
Erasca Inc
|
Independent Director |
702.5 K |
- |
2021 |
SpringWorks Therapeutics Inc
|
Independent Director |
477.5 K |
22.5 % |
2021 |
IGM Biosciences Inc
|
Independent Director |
457.3 K |
43.6 % |
2020 |
SpringWorks Therapeutics Inc
|
Independent Director |
389.7 K |
- |
2020 |
IGM Biosciences Inc
|
Independent Director |
318.5 K |
87.5 % |
2020 |
Erasca Inc
|
Independent Director |
- |
- |
2019 |
IGM Biosciences Inc
|
Independent Director |
169.8 K |
476.1 % |
2018 |
IGM Biosciences Inc
|
Independent Director |
29.5 K |
- |